Clinical Trial: Study of Escitalopram in the Treatment of Specific Phobia

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Placebo-Controlled Pilot Study of Escitalopram in the Treatment of Specific Phobia

Brief Summary: This pilot study is designed to assess the efficacy of escitalopram in the treatment of specific phobia in adult outpatients.

Detailed Summary: This double-blind placebo-controlled pilot trial study is designed to assess the efficacy of 12 weeks of escitalopram vs. placebo in the treatment of specific phobia in adult outpatients. It is hypothesized that escitalopram is safe and effective in the treatment of specific phobia.
Sponsor: Connor, Kathryn M., M.D.

Current Primary Outcome: Response based on a criterion of 50% or greater reduction in the Marks Main Phobia Questionnaire and Marks Fear Questionnaire from baseline

Original Primary Outcome: Same as current

Current Secondary Outcome: Response based on CGI-I category

Original Secondary Outcome: Same as current

Information By: Connor, Kathryn M., M.D.

Dates:
Date Received: July 13, 2005
Date Started: September 2002
Date Completion: September 2004
Last Updated: July 19, 2005
Last Verified: July 2005